Avastin Hearing's Deadline For Written Submissions Is Indefinitely Delayed
This article was originally published in The Pink Sheet Daily
Executive Summary
Presiding Officer Karen Midthun postpones the submission deadline for written summaries of arguments by Genentech and CDER until one week after the formal hearing notice is issued, although it remains unclear when that will occur.